Evidence map›Paper›PMID 37587904›Full record

ArticleClinical cardiology2023

Association among β2-adrenergic receptor autoantibodies and proximal left anterior descending artery lesions in patients with initial ST-segment elevation myocardial infarction.

Wenxi Dang, Ning Cao, Yue Zhang, Weiping Li, Hongwei Li

Open access · goldAbstract read
In one paragraph

Article in Clinical cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wenxi DangDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0003-3553-7556
Ning CaoDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0003-3961-3819
Yue ZhangDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Weiping LiDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-5534-5925
Hongwei LiDepartment of Cardiology, Cardiovascular Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0001-5900-7088
Capital Medical University · CN

Funding

Beijing Postdoctoral Research Foundation 2023-ZZ-007China Postdoctoral Science Foundation 2023M732406National Natural Science Foundation of China 82070357National Natural Science Foundation of China 82200284Research Foundation of Beijing Friendship Hospital, Capital Medical University yybsh2021013Research Foundation of Beijing Friendship Hospital, Capital Medical University yybsh2021013; YYZZ202206Research Foundation of Beijing Friendship Hospital, Capital Medical University YYZZ202206The National Key R&D Program of China 2021ZD0111000
6 · The paper itself

Abstract

backgroundβ HYPOTHESIS: β

methodsA cohort of 153 patients with STEMI who underwent primary percutaneous coronary intervention (PPCI) was enrolled in the study. Baseline characteristics were compared between the proximal LAD group (n = 62) and the nonproximal LAD group (n = 91). Admission serum of patients was collected to detect the level of β

resultsThe optical density values and positive rates of β

conclusionsThe STEMI patients with high β

Indexed as

Percutaneous Coronary InterventionST Elevation Myocardial InfarctionCoronary VesselsHumansPrognosisReceptors, AdrenergicReceptors, Adrenergic, beta-2ADRB2 protein, humanReceptors, AdrenergicReceptors, Adrenergic, beta-2primary percutaneous coronary interventionproximal left anterior descendingST-segment elevation myocardial infarctionβ2-adrenergic receptor autoantibody

Identifiers

PMID37587904
PMCPMC10642316
OpenAlexW4385898262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.